第六节 预防控制

更新于 2026年11月17日 版权声明
第六节 预防控制

SFTS 是一种病死率较高的出血热疾病,主要发生于中国、日本及韩国,且SFTS流行区域仍在逐渐扩大。据统计,目前报道的SFTS的病例数已超过1万。蜱虫叮咬是SFTSV的主要传播途径,人传人或动物传人的案例也有少量报道。然而,目前仍无针对SFTS治疗的药物及预防用的疫苗,主要采用对症及广谱抗病毒治疗。因此,对于SFTS的防控应主要采取以切断传播途径为主的防控措施,减少SFTSV暴露机会:①加强宣传教育,提高SFTS流行区域人群对SFTS对认知并加强自我保护意识,注意个人手部卫生。野外作业时,应加强个人防护,减少蜱虫叮咬机会。②对SFTS流行区域家养及野生动物蜱虫进行监测,并采用化学方法控制蜱虫,降低人群暴露在蜱虫的机会。③SFTS临床症状与其他出血热疾病症状类似,因此提高医务人员及实验室对SFTS的诊断、治疗及检测水平。④据报道,SFTSV可通过病人血液或体液传播。尽管目前无SFTS大规模社区爆发的案例。SFTS患者密切接触者,包括家人和医疗工作者都是SFTS的高危人群。因此,SFTS的密切接触者应当采取标准防护措施,严格避免接触SFTS患者血液或体液。⑤对SFTS患者应采取隔离措施,同时对SFTS患者的血液及相关接触物都应采取消毒处理。⑥)深入了解SFTS的致病机制及传播媒介,为相关治疗措施提供理论基础。⑦加强SFTSV相关预防性疫苗及治疗性中和抗体的研制。

(周传敏 于学杰)

参考文献

[1]Yu X J,Liang M F,Zhang S Y,et al.Fever with thrombocytopenia associated with a novel bunyavirus in China[J].N Engl Med,2011,364 (16) :1523-1532.

[2]Guu T S,Zheng W,Tao Y J.Bunyavirus:structure and replication[J].Adv Exp Med Biol,2012,726;245-266.

[3]Takahashi T,Maeda K,Suzuki T,et al.The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan[J].J Infecti Dis,2014,209 (6) :816-827.

[4]Kim K H,Yi J,Kim G,et al.Severe fever with thrombocytopenia syndrome,South Korea,2012[J].Emerg Infect Dis,2013,19 (11) :1892-1894.

[5]Tran X C,Yun Y,Van An L,et al.Endemic severe fever with thrombocytopenia syndrome,Vietnam[J].Emerg Infect Dis,2019,25 (5) :1029-1031.

[6]Gai Z T,Zhang Y,Liang M F,et al.Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients[J].J Infect Dis,2012,206 (7) :1095-1102.

[7]Yu X J.Risk factors for death in severe fever with thrombocytopenia syndrome[J].Lancet Infect Dis,2018,18 (10) :1056-1057.

[8]Jongejan F,Uilenberg G.The global importance of ticks[J].Parasitology,2004,129 Suppl:S3-14.

[9]NIOSH Workplace Safety and Health Topic.https://www.cdc.gov/niosh/topics/tickborne/default.html,C.-.Tick-Borne Diseases-[EB/OL].(2016-05-04)[2020-05-01].

[10]Hu Y Y,Zhuang L,Liu K,et al.Role of three tick species in the maintenance and transmission of Severe Fever with Thrombocytopenia Syndrome Virus[J].PLoS Negl Trop Dis,2020,14 (6) :e0008368.

[11]Luo L M,Zhao L,Wen H L,et al.Haemaphysalis longicornis ticks as reservoir and vector of severe fever with thrombocytopenia syndrome virus in China[J].Emerg Infect Dis,2015,21 (10) :1770-1776.

[12]Liu J W,Wen H L,Fang L Z,et al.Prevalence of SFTSV among Asian house shrews and rodents,China,January-August 2013[J].Emerg Infect Dis,2014,20 (12) :2126-2128.

[13]Sun Y,Liu M M,Luo L,et al.Seroprevalence of severe fever with thrombocytopenia syndrome virus in hedgehog from China[J].Vector Borne Zoonotic Dis,2017,17 (5) :347-350.

[14]Wen H L,Zhao L,Zhai S,et al.Severe fever with thrombocytopenia syndrome,Shandong Province,China,2011[J].Emerg Infect Dis,2014,20 (1) :1-5.

[15]Niu G,Li J,Liang M,et al.Severe fever with thrombocytopenia syndrome virus among domesticated animals,China[J].Emerg Infect Dis,2013,19 (5) :756-763.

[16]Liu Y,Li Q,Hu W,et al.Person-to-person transmission of severe fever with thrombocytopenia syndrome virus[J].Vector Borne Zoonotic Dis,2012,12 (2) :156-160.

[17]Jung I Y,Choi W,Kim J,et al.Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome[J].Clini Microbiol infect Dis,2019,25 (5) :633 e1-633 e4.

[18]Jiang X L,Zhang S,Jiang M,et al.A cluster of person-to-person transmission cases caused by SFTS virus in Penglai,China[J].Clini Microbiol Infect Dis,2015,21 (3) :274-279.

[19]Bao C J,Guo X L,Qi X,et al.A family cluster of infections by a newly recognized bunyavirus in eastern China,2007:further evidence of person-to-person transmission[J].Clini Infect Dis,2011,53 (12) :1208-1214.

[20]Fu Y,Li S,Zhang Z,et al.Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from Zhoushan Islands,China:implication for transmission across the ocean[J].Scientific Reports,2016,6:19563.

[21]Liu J W,Zhao L,Luo L M,et al.Molecular evolution and spatial transmission of severe fever with thrombocytopenia syndrome virus based on complete genome sequences[J].PLoS One,2016,11 (3) :e0151677.

[22]Mourya D T,Yadav P D,Basu A,et al.Malsoor virus,a novel bat phlebovirus,is closely related to severe fever with thrombocytopenia syndrome virus and heartland virus[J].J Virology,2014,88 (6) :3605-3609.

[23]Matsuno K,Weisend C,Travassos da Rosa A P,et al.Characterization of the Bhanja serogroup viruses (Bunyaviridae) :a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses[J].J Virology,2013,87 (7) :3719-3728.

[24]McMullan L K,Folk S M,Kelly A J,et al.A new phlebovirus associated with severe febrile illness in Missouri[J].N Engl J Med,2012,367 (9) :834-841.(https://www.daowen.com)

[25]Wang J,Selleck P,Yu M,et al.Novel phlebovirus with zoonotic potential isolated from ticks,Australia[J].Emerg Infect Dis,2014,20 (6) :1040-1043.

[26]Barbalat R,Ewald S E,Mouchess M L,et al.Nucleic acid recognition by the innate immune system[J].Annual Review Immunol,2011,29:185-214.

[27]Li S,Li H,Zhang Y L,et al.SFTSV Infection Induces BAK/BAX-dependent mitochondrial dna release to trigger NLRP3 inflammasome activation[J].Cell Reports,2020,30 (13) :4370-4385 e7.

[28]Ning Y J,Wang M,Deng M,et al.Viral suppression of innate immunity via spatial isolation of TBK1/IKKepsilon from mitochondrial antiviral platform[J].J Mole Cell Biology,2014,6 (4) :324-337.

[29]Santiago F W,Covaleda L M,Sanchez-Aparicio M T,et al.Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses[J].J Virol,2014,88 (8) :4572-4585.

[30]Ning Y J,Feng K,Min Y Q,et al.Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies[J].J Virol,2015,89 (8) :4227-4236.

[31]Wu X,Qi X,Liang M,et al.Roles of viroplasm-like structures formed by nonstructural protein NSs in infection with severe fever with thrombocytopenia syndrome virus[J].FASEB J,2014,28 (6) :2504-2516.

[32]Qu B,Qi X,Wu X,et al.Suppression of the interferon and NF-kappa B responses by severe fever with thrombocytopenia syndrome virus[J].J Virology,2012,86 (16) :8388-8401.

[33]Moriyama M,Kodama S,Hirano T,et al.Endoscopic-modified medial maxillectomy and its limitation for a solitary fibrous tumor of the lacrimal sac and nasolacrimal duct[J].Auris,nasus,larynx,2017,44 (3) :370-374.

[34]Liu W,Lu Q B,Cui N,et al.Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome[J].Clin infect Dis,2013,57 (9) :1292-1299.

[35]Shimojima M,Fukushi S,Tani H,et al.Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in vitro[J].Japanese J Infect Dis,2014,67 (6) :423-427.

[36]Tani H,Fukuma A,Fukushi S,et al.Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus[J].mSphere,2016,1(1) .

[37]Gowen B B,Westover J B,Miao J,et al.Modeling severe fever with thrombocytopenia syndrome virus infection in golden syrian hamsters:importance of STAT2 in preventing disease and effective treatment with favipiravir[J].J Virology,2017,91 (3) .

[38]Li H,Zhang L K,Li S F,et al.Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality[J].Cell Res,2019,29 (9) :739-753.

[39]Schoofs T,Klein F,Braunschweig M,et al.HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1[J].Science,2016,352 (6288) :997-1001.

[40]Scheid J F,Horwitz J A,Bar-On Y,et al.HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption[J].Nature,2016,535 (7613) :556-560.

[41]Caskey M,Klein F,Lorenzi J C,et al.Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117[J].Nature,2015,522 (7557) :487-491.

[42]Sun H,Chen Q,Lai H.Development of antibody therapeutics against flaviviruses[J].Internat J Molecul Sci,2017,19 (1) .

[43]Dai L,Song J,Lu X,et al.Structures of the zika virus envelope protein and its complex with a flavivirus broadly protective antibody[J].Cell Host Microbe,2016,19 (5) :696-704.

[44]Geisbert T W,Mire C E,Geisbert J B,et al.Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody[J].Sci Translation Med,2014,6 (242) :242ra82.

[45]Bossart K N,Geisbert T W,Feldmann H,et al.A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge[J].Sci translation Med,2011,3 (105) :105ra103.

[46]Guo X,Zhang L,Zhang W,et al.Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus,an emerging hemorrhagic Fever virus[J].Clin Vaccine Immunol :CVI 2013,20 (9) :1426-1432.

[47]Kim K H,Kim J,Ko M,et al.An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus[J].PLoS Pathogens,2019,15 (2) :e1007375.

[48]Zhu Y,Wu Y,Chai Y,et al.The postfusion structure of the heartland virus gc glycoprotein supports taxonomic separation of the bunyaviral families Phenuiviridae and Hantaviridae[J].J Virol,2018,92 (1) .

[49]Wu Y,Zhu Y,Gao F,et al.Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope[J].Proceed Nation Acad Sci USA,2017,114 (36) :E7564-E7573.

[50]Halldorsson S,Behrens A J,Harlos K,et al.Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion[J].Proceed Nation Acad Sci USA,2016,113 (26) :7154-7159.

✍AI写作